LeonaBio, Inc.

LONA ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
8-K Sep 22, 2026 8-K
3 Sep 3, 2026 PRIMARY DOCUMENT
SCHEDULE 13D Aug 31, 2026
8-K Aug 26, 2026 8-K
SCHEDULE 13D/A Aug 25, 2026
SCHEDULE 13G/A Aug 20, 2026
10-Q Aug 14, 2026 10-Q
8-K Aug 14, 2026 8-K
4 Jul 10, 2026 4
4 Jul 9, 2026 4
4 Jun 24, 2026
4 Jun 24, 2026
4 Jun 24, 2026
4 Jun 24, 2026
4 Jun 24, 2026
4 Jun 24, 2026
4 Jun 24, 2026
4 Jun 24, 2026
4 Jun 24, 2026
8-K Jun 23, 2026 8-K
SCHEDULE 13G May 15, 2026
ARS May 11, 2026 ARS
DEFA14A May 11, 2026 DEFA14A
DEF 14A May 11, 2026 DEF 14A
4 May 7, 2026
← Newer Page 1 of 19 · 464 filings Older →